Dechra Pharmaceuticals PLC
Dechra Pharmaceuticals PLC DCHPF Peers
See (DCHPF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DCHPF | $46.90 | -0.21% | 5.3B | -151.29 | -$0.31 | N/A |
| CLCGY | $42.99 | +0.44% | 20.4B | 30.71 | $1.40 | +0.09% |
| ALBHF | $0.67 | N/A | 10.7B | 66.60 | $0.01 | N/A |
| ALBBY | $11.09 | N/A | 8.9B | 44.36 | $0.25 | N/A |
| MSMKF | $18.11 | N/A | 7.3B | 19.47 | $0.93 | +1.66% |
| RADLY | $3.01 | +20.88% | 5.2B | 25.08 | $0.12 | +0.37% |
| RGEDF | $27.17 | N/A | 5B | 7.99 | $3.40 | +4.99% |
| GEDSF | $24.85 | N/A | 4.5B | 10.71 | $2.32 | +5.76% |
| CSMYF | $46.06 | N/A | 3.7B | 19.77 | $2.33 | +0.47% |
| WLCGF | $16.41 | N/A | 3.4B | 19.54 | $0.84 | +0.75% |
Stock Comparison
DCHPF vs CLCGY Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, CLCGY has a market cap of 20.4B. Regarding current trading prices, DCHPF is priced at $46.90, while CLCGY trades at $42.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas CLCGY's P/E ratio is 30.71. In terms of profitability, DCHPF's ROE is N/A, compared to CLCGY's ROE of +0.49%. Regarding short-term risk, DCHPF is less volatile compared to CLCGY. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs ALBHF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, ALBHF has a market cap of 10.7B. Regarding current trading prices, DCHPF is priced at $46.90, while ALBHF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas ALBHF's P/E ratio is 66.60. In terms of profitability, DCHPF's ROE is N/A, compared to ALBHF's ROE of +0.06%. Regarding short-term risk, DCHPF is less volatile compared to ALBHF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs ALBBY Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, ALBBY has a market cap of 8.9B. Regarding current trading prices, DCHPF is priced at $46.90, while ALBBY trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas ALBBY's P/E ratio is 44.36. In terms of profitability, DCHPF's ROE is N/A, compared to ALBBY's ROE of +0.06%. Regarding short-term risk, DCHPF is less volatile compared to ALBBY. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs MSMKF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, MSMKF has a market cap of 7.3B. Regarding current trading prices, DCHPF is priced at $46.90, while MSMKF trades at $18.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas MSMKF's P/E ratio is 19.47. In terms of profitability, DCHPF's ROE is N/A, compared to MSMKF's ROE of +0.07%. Regarding short-term risk, DCHPF is less volatile compared to MSMKF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs RADLY Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, RADLY has a market cap of 5.2B. Regarding current trading prices, DCHPF is priced at $46.90, while RADLY trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas RADLY's P/E ratio is 25.08. In terms of profitability, DCHPF's ROE is N/A, compared to RADLY's ROE of +0.18%. Regarding short-term risk, DCHPF is less volatile compared to RADLY. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs RGEDF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, RGEDF has a market cap of 5B. Regarding current trading prices, DCHPF is priced at $46.90, while RGEDF trades at $27.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas RGEDF's P/E ratio is 7.99. In terms of profitability, DCHPF's ROE is N/A, compared to RGEDF's ROE of +0.20%. Regarding short-term risk, DCHPF is less volatile compared to RGEDF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs GEDSF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, GEDSF has a market cap of 4.5B. Regarding current trading prices, DCHPF is priced at $46.90, while GEDSF trades at $24.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas GEDSF's P/E ratio is 10.71. In terms of profitability, DCHPF's ROE is N/A, compared to GEDSF's ROE of +0.15%. Regarding short-term risk, DCHPF and GEDSF have similar daily volatility (0.00).
DCHPF vs CSMYF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, CSMYF has a market cap of 3.7B. Regarding current trading prices, DCHPF is priced at $46.90, while CSMYF trades at $46.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas CSMYF's P/E ratio is 19.77. In terms of profitability, DCHPF's ROE is N/A, compared to CSMYF's ROE of +0.08%. Regarding short-term risk, DCHPF is less volatile compared to CSMYF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs WLCGF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, WLCGF has a market cap of 3.4B. Regarding current trading prices, DCHPF is priced at $46.90, while WLCGF trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas WLCGF's P/E ratio is 19.54. In terms of profitability, DCHPF's ROE is N/A, compared to WLCGF's ROE of +0.07%. Regarding short-term risk, DCHPF and WLCGF have similar daily volatility (0.00).
DCHPF vs SDGCF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, SDGCF has a market cap of 3.3B. Regarding current trading prices, DCHPF is priced at $46.90, while SDGCF trades at $28.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas SDGCF's P/E ratio is 17.40. In terms of profitability, DCHPF's ROE is N/A, compared to SDGCF's ROE of +0.05%. Regarding short-term risk, DCHPF and SDGCF have similar daily volatility (0.00).
DCHPF vs SHPPF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, SHPPF has a market cap of 3B. Regarding current trading prices, DCHPF is priced at $46.90, while SHPPF trades at $148.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas SHPPF's P/E ratio is -54.09. In terms of profitability, DCHPF's ROE is N/A, compared to SHPPF's ROE of -0.09%. Regarding short-term risk, DCHPF is less volatile compared to SHPPF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs SGIPF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, SGIPF has a market cap of 2.9B. Regarding current trading prices, DCHPF is priced at $46.90, while SGIPF trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas SGIPF's P/E ratio is 20.11. In terms of profitability, DCHPF's ROE is N/A, compared to SGIPF's ROE of +0.11%. Regarding short-term risk, DCHPF and SGIPF have similar daily volatility (0.00).
DCHPF vs TSUSF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, TSUSF has a market cap of 2.7B. Regarding current trading prices, DCHPF is priced at $46.90, while TSUSF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas TSUSF's P/E ratio is 16.87. In terms of profitability, DCHPF's ROE is N/A, compared to TSUSF's ROE of +0.06%. Regarding short-term risk, DCHPF is less volatile compared to TSUSF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs SAEYY Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, SAEYY has a market cap of 2.5B. Regarding current trading prices, DCHPF is priced at $46.90, while SAEYY trades at $12.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas SAEYY's P/E ratio is -45.56. In terms of profitability, DCHPF's ROE is N/A, compared to SAEYY's ROE of -0.09%. Regarding short-term risk, DCHPF and SAEYY have similar daily volatility (0.00).
DCHPF vs HTSUY Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, HTSUY has a market cap of 2.2B. Regarding current trading prices, DCHPF is priced at $46.90, while HTSUY trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas HTSUY's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to HTSUY's ROE of +0.08%. Regarding short-term risk, DCHPF is less volatile compared to HTSUY. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs BJTRF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, BJTRF has a market cap of 542.8M. Regarding current trading prices, DCHPF is priced at $46.90, while BJTRF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas BJTRF's P/E ratio is 8.10. In terms of profitability, DCHPF's ROE is N/A, compared to BJTRF's ROE of +0.03%. Regarding short-term risk, DCHPF is less volatile compared to BJTRF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs ZRSEF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, ZRSEF has a market cap of 411.7M. Regarding current trading prices, DCHPF is priced at $46.90, while ZRSEF trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas ZRSEF's P/E ratio is -2.14. In terms of profitability, DCHPF's ROE is N/A, compared to ZRSEF's ROE of -0.26%. Regarding short-term risk, DCHPF is less volatile compared to ZRSEF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs NVACF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, NVACF has a market cap of 78.5M. Regarding current trading prices, DCHPF is priced at $46.90, while NVACF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas NVACF's P/E ratio is 31.60. In terms of profitability, DCHPF's ROE is N/A, compared to NVACF's ROE of +0.02%. Regarding short-term risk, DCHPF is less volatile compared to NVACF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs KIARF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, KIARF has a market cap of 67.4M. Regarding current trading prices, DCHPF is priced at $46.90, while KIARF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas KIARF's P/E ratio is -0.01. In terms of profitability, DCHPF's ROE is N/A, compared to KIARF's ROE of -1.47%. Regarding short-term risk, DCHPF and KIARF have similar daily volatility (0.00).
DCHPF vs HTPRF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, HTPRF has a market cap of 12.1M. Regarding current trading prices, DCHPF is priced at $46.90, while HTPRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas HTPRF's P/E ratio is -0.06. In terms of profitability, DCHPF's ROE is N/A, compared to HTPRF's ROE of +0.11%. Regarding short-term risk, DCHPF and HTPRF have similar daily volatility (0.00).
DCHPF vs ETBI Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, ETBI has a market cap of 9M. Regarding current trading prices, DCHPF is priced at $46.90, while ETBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas ETBI's P/E ratio is -0.40. In terms of profitability, DCHPF's ROE is N/A, compared to ETBI's ROE of +0.00%. Regarding short-term risk, DCHPF and ETBI have similar daily volatility (0.00).
DCHPF vs PNPL Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, PNPL has a market cap of 7.3M. Regarding current trading prices, DCHPF is priced at $46.90, while PNPL trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas PNPL's P/E ratio is -10.00. In terms of profitability, DCHPF's ROE is N/A, compared to PNPL's ROE of +0.54%. Regarding short-term risk, DCHPF and PNPL have similar daily volatility (0.00).
DCHPF vs FFLWF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, FFLWF has a market cap of 5.4M. Regarding current trading prices, DCHPF is priced at $46.90, while FFLWF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas FFLWF's P/E ratio is -0.08. In terms of profitability, DCHPF's ROE is N/A, compared to FFLWF's ROE of -0.97%. Regarding short-term risk, DCHPF is less volatile compared to FFLWF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs RLLVF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, RLLVF has a market cap of 5.3M. Regarding current trading prices, DCHPF is priced at $46.90, while RLLVF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas RLLVF's P/E ratio is -0.60. In terms of profitability, DCHPF's ROE is N/A, compared to RLLVF's ROE of +2.21%. Regarding short-term risk, DCHPF and RLLVF have similar daily volatility (0.00).
DCHPF vs HEWA Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, HEWA has a market cap of 3.8M. Regarding current trading prices, DCHPF is priced at $46.90, while HEWA trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas HEWA's P/E ratio is -2.94. In terms of profitability, DCHPF's ROE is N/A, compared to HEWA's ROE of +0.08%. Regarding short-term risk, DCHPF is less volatile compared to HEWA. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs LGNZZ Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, LGNZZ has a market cap of 2.7M. Regarding current trading prices, DCHPF is priced at $46.90, while LGNZZ trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas LGNZZ's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to LGNZZ's ROE of -0.16%. Regarding short-term risk, DCHPF and LGNZZ have similar daily volatility (0.00).
DCHPF vs GABLF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, GABLF has a market cap of 2.7M. Regarding current trading prices, DCHPF is priced at $46.90, while GABLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas GABLF's P/E ratio is -0.04. In terms of profitability, DCHPF's ROE is N/A, compared to GABLF's ROE of +2.91%. Regarding short-term risk, DCHPF and GABLF have similar daily volatility (0.00).
DCHPF vs SYDRF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, SYDRF has a market cap of 2.3M. Regarding current trading prices, DCHPF is priced at $46.90, while SYDRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas SYDRF's P/E ratio is 8.00. In terms of profitability, DCHPF's ROE is N/A, compared to SYDRF's ROE of +0.96%. Regarding short-term risk, DCHPF is less volatile compared to SYDRF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs CAFS Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, CAFS has a market cap of 2M. Regarding current trading prices, DCHPF is priced at $46.90, while CAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas CAFS's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to CAFS's ROE of +1.94%. Regarding short-term risk, DCHPF and CAFS have similar daily volatility (0.00).
DCHPF vs IWINF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, IWINF has a market cap of 1.7M. Regarding current trading prices, DCHPF is priced at $46.90, while IWINF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas IWINF's P/E ratio is -0.06. In terms of profitability, DCHPF's ROE is N/A, compared to IWINF's ROE of -0.21%. Regarding short-term risk, DCHPF and IWINF have similar daily volatility (0.00).
DCHPF vs NUTTQ Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, NUTTQ has a market cap of 1.1M. Regarding current trading prices, DCHPF is priced at $46.90, while NUTTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas NUTTQ's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to NUTTQ's ROE of +3.01%. Regarding short-term risk, DCHPF is less volatile compared to NUTTQ. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs CNBI Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, CNBI has a market cap of 686.8K. Regarding current trading prices, DCHPF is priced at $46.90, while CNBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas CNBI's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to CNBI's ROE of +0.17%. Regarding short-term risk, DCHPF is less volatile compared to CNBI. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs LGNYZ Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, LGNYZ has a market cap of 675.3K. Regarding current trading prices, DCHPF is priced at $46.90, while LGNYZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas LGNYZ's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to LGNYZ's ROE of -0.16%. Regarding short-term risk, DCHPF and LGNYZ have similar daily volatility (0.00).
DCHPF vs RADCQ Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, RADCQ has a market cap of 559.7K. Regarding current trading prices, DCHPF is priced at $46.90, while RADCQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas RADCQ's P/E ratio is -0.00. In terms of profitability, DCHPF's ROE is N/A, compared to RADCQ's ROE of +3.01%. Regarding short-term risk, DCHPF is less volatile compared to RADCQ. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs AEGY Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, AEGY has a market cap of 411.2K. Regarding current trading prices, DCHPF is priced at $46.90, while AEGY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas AEGY's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to AEGY's ROE of +0.00%. Regarding short-term risk, DCHPF is less volatile compared to AEGY. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs IPAH Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, IPAH has a market cap of 273.6K. Regarding current trading prices, DCHPF is priced at $46.90, while IPAH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas IPAH's P/E ratio is -0.05. In terms of profitability, DCHPF's ROE is N/A, compared to IPAH's ROE of -0.82%. Regarding short-term risk, DCHPF is less volatile compared to IPAH. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs FOGCF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, FOGCF has a market cap of 97.2K. Regarding current trading prices, DCHPF is priced at $46.90, while FOGCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas FOGCF's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to FOGCF's ROE of +3.99%. Regarding short-term risk, DCHPF is less volatile compared to FOGCF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs MDIN Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, MDIN has a market cap of 90.3K. Regarding current trading prices, DCHPF is priced at $46.90, while MDIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas MDIN's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to MDIN's ROE of +0.36%. Regarding short-term risk, DCHPF is less volatile compared to MDIN. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs OXIHF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, OXIHF has a market cap of 65.7K. Regarding current trading prices, DCHPF is priced at $46.90, while OXIHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas OXIHF's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to OXIHF's ROE of +3.30%. Regarding short-term risk, DCHPF is less volatile compared to OXIHF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs HADV Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, HADV has a market cap of 64.4K. Regarding current trading prices, DCHPF is priced at $46.90, while HADV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas HADV's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to HADV's ROE of +0.83%. Regarding short-term risk, DCHPF is less volatile compared to HADV. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs IMMB Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, IMMB has a market cap of 57.5K. Regarding current trading prices, DCHPF is priced at $46.90, while IMMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas IMMB's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to IMMB's ROE of -0.09%. Regarding short-term risk, DCHPF and IMMB have similar daily volatility (0.00).
DCHPF vs RBII Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, RBII has a market cap of 49.9K. Regarding current trading prices, DCHPF is priced at $46.90, while RBII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas RBII's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to RBII's ROE of -0.04%. Regarding short-term risk, DCHPF is less volatile compared to RBII. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs LGNDZ Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, LGNDZ has a market cap of 38.6K. Regarding current trading prices, DCHPF is priced at $46.90, while LGNDZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas LGNDZ's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to LGNDZ's ROE of -0.16%. Regarding short-term risk, DCHPF and LGNDZ have similar daily volatility (0.00).
DCHPF vs DECN Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, DECN has a market cap of 35.5K. Regarding current trading prices, DCHPF is priced at $46.90, while DECN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas DECN's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to DECN's ROE of +0.00%. Regarding short-term risk, DCHPF and DECN have similar daily volatility (0.00).
DCHPF vs SPPH Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, SPPH has a market cap of 29.4K. Regarding current trading prices, DCHPF is priced at $46.90, while SPPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas SPPH's P/E ratio is -0.03. In terms of profitability, DCHPF's ROE is N/A, compared to SPPH's ROE of -0.50%. Regarding short-term risk, DCHPF is less volatile compared to SPPH. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs LGNXZ Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, LGNXZ has a market cap of 25.1K. Regarding current trading prices, DCHPF is priced at $46.90, while LGNXZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas LGNXZ's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to LGNXZ's ROE of -0.16%. Regarding short-term risk, DCHPF is less volatile compared to LGNXZ. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs WPHM Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, WPHM has a market cap of 23.2K. Regarding current trading prices, DCHPF is priced at $46.90, while WPHM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas WPHM's P/E ratio is -0.01. In terms of profitability, DCHPF's ROE is N/A, compared to WPHM's ROE of -1.56%. Regarding short-term risk, DCHPF is less volatile compared to WPHM. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs SCRCQ Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, SCRCQ has a market cap of 14.1K. Regarding current trading prices, DCHPF is priced at $46.90, while SCRCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas SCRCQ's P/E ratio is -0.01. In terms of profitability, DCHPF's ROE is N/A, compared to SCRCQ's ROE of +1.63%. Regarding short-term risk, DCHPF is less volatile compared to SCRCQ. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs TSTS Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, TSTS has a market cap of 12.8K. Regarding current trading prices, DCHPF is priced at $46.90, while TSTS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas TSTS's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to TSTS's ROE of +2.32%. Regarding short-term risk, DCHPF is less volatile compared to TSTS. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs IXSBF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, IXSBF has a market cap of 12.6K. Regarding current trading prices, DCHPF is priced at $46.90, while IXSBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas IXSBF's P/E ratio is -0.01. In terms of profitability, DCHPF's ROE is N/A, compared to IXSBF's ROE of +1.90%. Regarding short-term risk, DCHPF is less volatile compared to IXSBF. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs VIAP Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, VIAP has a market cap of 10.3K. Regarding current trading prices, DCHPF is priced at $46.90, while VIAP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas VIAP's P/E ratio is -0.05. In terms of profitability, DCHPF's ROE is N/A, compared to VIAP's ROE of +0.65%. Regarding short-term risk, DCHPF is less volatile compared to VIAP. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs OMHE Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, OMHE has a market cap of 9.8K. Regarding current trading prices, DCHPF is priced at $46.90, while OMHE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas OMHE's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to OMHE's ROE of +0.73%. Regarding short-term risk, DCHPF is less volatile compared to OMHE. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs ALST Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, ALST has a market cap of 8.4K. Regarding current trading prices, DCHPF is priced at $46.90, while ALST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas ALST's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to ALST's ROE of +0.13%. Regarding short-term risk, DCHPF is less volatile compared to ALST. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs HBOSF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, HBOSF has a market cap of 7.8K. Regarding current trading prices, DCHPF is priced at $46.90, while HBOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas HBOSF's P/E ratio is 0.03. In terms of profitability, DCHPF's ROE is N/A, compared to HBOSF's ROE of +6.69%. Regarding short-term risk, DCHPF and HBOSF have similar daily volatility (0.00).
DCHPF vs PXYN Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, PXYN has a market cap of 6.3K. Regarding current trading prices, DCHPF is priced at $46.90, while PXYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas PXYN's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to PXYN's ROE of -0.20%. Regarding short-term risk, DCHPF is less volatile compared to PXYN. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs IYXI Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, IYXI has a market cap of 5.3K. Regarding current trading prices, DCHPF is priced at $46.90, while IYXI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas IYXI's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to IYXI's ROE of +1.71%. Regarding short-term risk, DCHPF and IYXI have similar daily volatility (0.00).
DCHPF vs NEWG Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, NEWG has a market cap of 2.3K. Regarding current trading prices, DCHPF is priced at $46.90, while NEWG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas NEWG's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to NEWG's ROE of +0.40%. Regarding short-term risk, DCHPF is less volatile compared to NEWG. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs FSPM Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, FSPM has a market cap of 1.3K. Regarding current trading prices, DCHPF is priced at $46.90, while FSPM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas FSPM's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to FSPM's ROE of N/A. Regarding short-term risk, DCHPF and FSPM have similar daily volatility (0.00).
DCHPF vs GRPI Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, GRPI has a market cap of 1K. Regarding current trading prices, DCHPF is priced at $46.90, while GRPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas GRPI's P/E ratio is -0.02. In terms of profitability, DCHPF's ROE is N/A, compared to GRPI's ROE of +0.09%. Regarding short-term risk, DCHPF and GRPI have similar daily volatility (0.00).
DCHPF vs AXMP Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, AXMP has a market cap of 409. Regarding current trading prices, DCHPF is priced at $46.90, while AXMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas AXMP's P/E ratio is 0.00. In terms of profitability, DCHPF's ROE is N/A, compared to AXMP's ROE of N/A. Regarding short-term risk, DCHPF and AXMP have similar daily volatility (0.00).
DCHPF vs ACGJ Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, ACGJ has a market cap of 324. Regarding current trading prices, DCHPF is priced at $46.90, while ACGJ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas ACGJ's P/E ratio is -0.00. In terms of profitability, DCHPF's ROE is N/A, compared to ACGJ's ROE of N/A. Regarding short-term risk, DCHPF and ACGJ have similar daily volatility (0.00).
DCHPF vs MDVLQ Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, MDVLQ has a market cap of 161. Regarding current trading prices, DCHPF is priced at $46.90, while MDVLQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas MDVLQ's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to MDVLQ's ROE of -2.39%. Regarding short-term risk, DCHPF is less volatile compared to MDVLQ. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs ISHI Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, ISHI has a market cap of 5. Regarding current trading prices, DCHPF is priced at $46.90, while ISHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas ISHI's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to ISHI's ROE of N/A. Regarding short-term risk, DCHPF is less volatile compared to ISHI. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs SYNI Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, SYNI has a market cap of 3. Regarding current trading prices, DCHPF is priced at $46.90, while SYNI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas SYNI's P/E ratio is -0.00. In terms of profitability, DCHPF's ROE is N/A, compared to SYNI's ROE of N/A. Regarding short-term risk, DCHPF and SYNI have similar daily volatility (0.00).
DCHPF vs MDSI Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, MDSI has a market cap of 0. Regarding current trading prices, DCHPF is priced at $46.90, while MDSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas MDSI's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to MDSI's ROE of N/A. Regarding short-term risk, DCHPF and MDSI have similar daily volatility (0.00).
DCHPF vs GHTI Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, GHTI has a market cap of 0. Regarding current trading prices, DCHPF is priced at $46.90, while GHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas GHTI's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to GHTI's ROE of N/A. Regarding short-term risk, DCHPF is less volatile compared to GHTI. This indicates potentially lower risk in terms of short-term price fluctuations for DCHPF.
DCHPF vs TFSHF Comparison
DCHPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCHPF stands at 5.3B. In comparison, TFSHF has a market cap of 0. Regarding current trading prices, DCHPF is priced at $46.90, while TFSHF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCHPF currently has a P/E ratio of -151.29, whereas TFSHF's P/E ratio is N/A. In terms of profitability, DCHPF's ROE is N/A, compared to TFSHF's ROE of N/A. Regarding short-term risk, DCHPF and TFSHF have similar daily volatility (0.00).